Formin-2 nucleic acids and polypeptides and uses thereof
OwnerPhilip Leder, Benjamin Leaderinventors
Life of this patent
Estimating the term…
Abstract
The invention features methods and reagents for diagnosing and treating recurrent pregnancy loss by using formin-2 nucleic acids and polypeptides that have been identified to play a role in oocyte development.
Claims6
A method for determining whether a patient has an increased risk for recurrent pregnancy loss, said method comprising determining whether a formin-2 gene of said patient has a mutation, wherein a mutation indicates that said patient has an increased risk for recurrent pregnancy loss.
A method for determining whether a patient has an increased risk for recurrent pregnancy loss, said method comprising measuring formin-2 biological activity in said patient or in a cell from said patient, wherein decreased levels in said formin-2 biological activity, relative to normal levels, indicates that said patient has an increased risk for recurrent pregnancy loss.
A method for determining whether a patient has an increased risk for recurrent pregnancy loss, said method comprising measuring formin-2 expression in said patient or in a cell from said patient, wherein decreased levels in said formin-2 expression relative to normal levels, indicates that said patient has an increased risk for recurrent pregnancy loss.
A method for determining whether a person has an altered risk for recurrent pregnancy loss, comprising examining the person's formin-2 gene for polymorphisms, wherein the presence of a polymorphism associated with recurrent pregnancy loss indicates the person has an altered risk for recurrent pregnancy loss.
Dependencies are inferred from the claim text.